Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-GT™
HUGO-Ab™
Humanized Target Gene Models
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Drug Discovery and Development
Antibody Discovery Platform
HUGO-Mab™
HUGO-Light™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Metabolic & Cardiovascular
Obesity
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Innovative Drug R&D
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
Peer-Reviewed Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Corporate Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login
HomeMouseAtlas
C57BL/6JCya-Osbpl5em1flox/Cya
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Catalog Type
Product Name
Main Area of Research
How did you hear about us?
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.

C57BL/6JCya-Osbpl5em1flox/Cya

Common Name
Osbpl5-flox
Product ID
S-CKO-16911
Backgroud
C57BL/6JCya
Strain ID
CKOCMP-79196-Osbpl5-B6J-VA
Status
Research and Development
When using this mouse strain in a publication, please cite “Osbpl5-flox Mouse (Catalog S-CKO-16911) were purchased from Cyagen.”
cKO Models
Product Type
Age
Genotype
Sex
Quantity
The standard delivery applies for a guaranteed minimum of three heterozygous carriers. Breeding services for homozygous carriers and/or specified sex are available.
+
cKO Models
Basic Information
Strain Name
Osbpl5-flox
Strain ID
CKOCMP-79196-Osbpl5-B6J-VA
Gene Name
Osbpl5
Product ID
S-CKO-16911
Gene Alias
ORP5, Obph1, Osbp2, 1110006M06Rik
Background
C57BL/6JCya
NCBI ID
79196 (Mouse)
Modification
Conditional knockout
Chromosome
Chr 7 (Mouse)
Phenotype
MGI:1930265
Datasheet
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Strain Description
Ensembl Transcript ID
ENSMUST00000020411
NCBI Transcript ID
NM_024289
Target Region
Exon 2
Size of Effective Region
~1.3 kb
Overview of Gene Research
Osbpl5, or oxysterol binding protein like 5, is involved in lipid metabolism and phosphatidylinositol homeostasis. It may play a role in pathways related to cell survival, such as the AKT survival pathway [2]. The gene is also associated with cholesterol transport [3].

In non-small cell lung cancer (NSCLC), knockdown of Osbpl5 suppressed cell proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT) process. It was identified as a downstream target of miR-526b-3p, and lncRNA LMCD1-AS1 served as a sponge for miR-526b-3p, forming an axis that promotes NSCLC cell progression [1].

In transient cerebral ischemia, conditional knockout mice showed that abolishing the Osbpl5 gene (as part of a circRNA-mediated pathway) significantly inhibited apoptosis and autophagy, suggesting its role in phosphatidylinositol homeostasis between the plasma membrane and endoplasmic reticulum [2].

In ovarian cancer, knockdown of ARL4C, which affects Osbpl5 expression via the Notch-RBP-Jκ-H3K4Me3 pathway, disrupted cholesterol transport from lysosomes to the endoplasmic reticulum and autophagy, attenuating the resistance of ovarian cancer to carboplatin [3].

In summary, Osbpl5 is crucial for lipid-related cellular functions and homeostasis. Gene-knockout and related models have revealed its significance in diseases like NSCLC, transient cerebral ischemia, and ovarian cancer drug resistance, highlighting its potential as a therapeutic target in these disease areas.

References:
1. Hu, Rui, Yu, Yankai, Wang, Haining. 2022. The LMCD1-AS1/miR-526b-3p/OSBPL5 axis promotes cell proliferation, migration and invasion in non-small cell lung cancer. In BMC pulmonary medicine, 22, 30. doi:10.1186/s12890-022-01820-7. https://pubmed.ncbi.nlm.nih.gov/35000595/
2. Shang, Fei-Fei, Luo, Li, Yan, Jianghong, He, Xiang, Liu, Wei. 2020. CircRNA_0001449 disturbs phosphatidylinositol homeostasis and AKT activity by enhancing Osbpl5 translation in transient cerebral ischemia. In Redox biology, 34, 101459. doi:10.1016/j.redox.2020.101459. https://pubmed.ncbi.nlm.nih.gov/32086008/
3. Yang, Juan, Peng, Shuping, Zhang, Keqiang. . ARL4C depletion suppresses the resistance of ovarian cancer to carboplatin by disrupting cholesterol transport and autophagy via notch-RBP-Jκ-H3K4Me3-OSBPL5. In Human & experimental toxicology, 41, 9603271221135064. doi:10.1177/09603271221135064. https://pubmed.ncbi.nlm.nih.gov/36366750/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Inquiry Details
Main Area of Research
Service(s) of Interest
Gene of Interest
Project Details
How did you hear about us?
Contact Information
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our  Privacy Policy  for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCorporate OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Global Antibody Drug Industry Development BlueBook (Frost & Sullivan)
Key Insights
The industry is undergoing a rapid transformation driven by next-generation modalities, globalized markets, and upstream technological innovations.
  • Market Structural Shift: Monoclonal antibodies drive steady growth, but ADCs and bispecifics are rapidly accelerating, reshaping the market with higher-value innovations.
  • Chinese Market Globalization: China is actively expanding globally, evidenced by a surge in high-value cross-border license-out deals.
  • Technology-Driven Efficiency: Advanced discovery engines—exemplified by Cyagen's HUGO-Ab platform and AI algorithms—are streamlining candidate screening, optimizing molecular design, and localizing the upstream supply chain.
  • Oncology-Focused Innovation: R&D pipelines remain heavily concentrated on high-incidence malignancies like non-small cell lung cancer, utilizing complex modalities to combat clinical resistance.
Now Available for Download
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research